Viral Persistence | Pandemic PACT Tracker

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$960,894.38
Funder
UK Research and Innovation (UKRI)
Principal Investigator
Prof. V Nair
Research Location
United Kingdom
Lead Research Institution
The Pirbright Institute
Research Priority Alignment
N/A

Research Category
N/A
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

PI: Enhanced host responses for disease control: a BBSRC Strategic Programme

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Specific and Sensitive Visual Proviral DNA Detection of Major Pathogenic Avian Leukosis Virus Subgroups Using CRISPR-Associated Nuclease Cas13a.

Viral miRNA delivered by exosomes from Marek's disease virus-transformed lymphoma cell line exerts regulatory function in internalized primary chicken embryo fibroblast cells.

The Identification of Host Proteins That Interact with Non-Structural Proteins-1α and -1β of Porcine Reproductive and Respiratory Syndrome Virus-1.

Risk assessment of the newly emerged H7N9 avian influenza viruses.

CD4⁺TGFβ⁺ cells infiltrated the bursa of Fabricius following IBDV infection, and correlated with a delayed viral clearance, but did not correlate with disease severity, or immunosuppression.

Inhibition of Marek's Disease Virus Replication and Spread by 25-hydroxycholesterol and 27-hydroxycholesterol In Vitro.

Preventing bacterial disease in poultry in the post-antibiotic era: a case for innate immunity modulation as an alternative to antibiotic use.

Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins.

Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus.